UVADEX is a Extracorporeal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Therakos, Inc.. The primary component is Methoxsalen.
Product ID | 64067-216_6c5b68f2-b4b9-434b-9036-22d1b37bf68b |
NDC | 64067-216 |
Product Type | Human Prescription Drug |
Proprietary Name | UVADEX |
Generic Name | Methoxsalen |
Dosage Form | Injection, Solution |
Route of Administration | EXTRACORPOREAL |
Marketing Start Date | 1999-02-25 |
Marketing Category | NDA / NDA |
Application Number | NDA020969 |
Labeler Name | Therakos, Inc. |
Substance Name | METHOXSALEN |
Active Ingredient Strength | 20 ug/mL |
Pharm Classes | Psoralen [EPC],Psoralens [CS],Photoabsorption [MoA],Photoactivated Radical Generator [EPC],Photosensitizing Activity [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 1999-02-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020969 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1999-02-25 |
Ingredient | Strength |
---|---|
METHOXSALEN | 20 ug/mL |
SPL SET ID: | 5ad333bd-845f-43f8-9ecf-43491f26c7c7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
64067-216 | UVADEX | Methoxsalen |
45963-325 | Methoxsalen | Methoxsalen |
64380-752 | Methoxsalen | Methoxsalen |
68682-065 | Methoxsalen | Methoxsalen |
0187-0650 | Oxsoralen-Ultra | Methoxsalen |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
UVADEX 85319332 4074104 Live/Registered |
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED 2011-05-12 |
UVADEX 77489275 4006506 Live/Registered |
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED 2008-06-03 |
UVADEX 76549044 2891030 Dead/Cancelled |
JOHNSON & JOHNSON 2003-10-06 |
UVADEX 73169280 1119084 Dead/Expired |
HOFFMANN-LA ROCHE INC. 1978-05-05 |